| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.04 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-05 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.03 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.03 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.18 | 0.03 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.19 | 0.001 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.01 |